Trial intelligence / Profile preview

Intranasal dexmedetomidine sedation and analgesia during minor procedures in the pediatric emergency room

2017-001297-41Phase 4Active

Sponsor
Oulu University Hospital
Start
Dec 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of dexmedetomidine (2 arms), sponsored by Oulu University Hospital. Primary endpoint: Success of procedure at first attempt. Started Dec 2017; status: active.

02

Drugs

dexmedetomidine

Beyond the preview

Go deeper on 2017-001297-41.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2017-001297-41.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call